(JAMA Neurology) About 170 multiple sclerosis (MS) patients at Charing Cross Hospital in London reported side effects, including relapses, after being switched from Tysabri brand of natalizumab to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback